NutriBand (NTRB) Net Equity Issued and Repurchased (2016 - 2025)
NutriBand (NTRB) posted Net Equity Issued and Repurchased of $6591.0 for Q1 2025, down 99.92% sequentially from $8.4 million in Q2 2024.
NutriBand (NTRB) Net Equity Issued and Repurchased (2016 - 2025) Analysis & Trends
NutriBand has reported Net Equity Issued and Repurchased for 8 years, with the latest figure at $6591.0 in Q1 2025.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $6591.0 in Q1 2025, while the trailing twelve-month figure through Jan 2026 was $6591.0 (down 99.92% YoY) and the FY2026 annual result came in at $5.3 million, down 36.89% from the prior year.
- Net Equity Issued and Repurchased declined to $6591.0 in Q1 2025 per NTRB's latest filing, from $8.4 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $8.4 million in Q2 2024 and troughed at $6591.0 in Q1 2025.
- A 3-year average of $3.0 million and a median of $583000.0 in 2021 frame the typical range for Net Equity Issued and Repurchased.
- The widest YoY moves for Net Equity Issued and Repurchased: up 13.18% in 2021, down 13.18% in 2021.
- Over 3 years, Net Equity Issued and Repurchased stood at $583000.0 in 2021, then soared by 1340.82% to $8.4 million in 2024, then slumped by 99.92% to $6591.0 in 2025.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $6591.0, $8.4 million, and $583000.0 for Q1 2025, Q2 2024, and Q2 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2025 | 6,591.00 |
| Jan 31, 2025 | 6,591.00 |
| Apr 30, 2024 | 8.40 Mn |
| Apr 30, 2024 | 8.40 Mn |
| Apr 30, 2021 | 583,000.00 |
| Apr 30, 2021 | 583,000.00 |
| Apr 30, 2020 | 515,108.00 |
| Apr 30, 2020 | 515,108.00 |
| Jan 31, 2019 | 500,000.00 |
| Jan 31, 2019 | 500,000.00 |
| Jan 31, 2018 | 10,000.00 |
| Jan 31, 2018 | 10,000.00 |
| Jan 31, 2017 | 75,000.00 |
| Jan 31, 2017 | 75,000.00 |
| Apr 30, 2016 | 100,000.00 |
| Apr 30, 2016 | 100,000.00 |